Nephrocare Health Services logo
Allotment Out

mainboardBSE, NSE

Nephrocare Health Services

IPO GMP Today

₹32.02

Est. listing gain: 6.96%

Last updated: 2 Jan 2026 12:03 am

Nephrocare Health Services IPO Subscription Details
LIVE
Last Updated: 2 Jan 2026 12:03 am
QIB26.82x
NII24.77x
Retail2.35x
bNII30.43x
sNII13.46x
Total14.08x

Overall Subscription Details: 14.08 times

Open

Dec 10, 2025

Close

Dec 12, 2025

BOA

15 Dec 2025

Refunds

16 Dec 2025

Listing

17 Dec 2025

Nephrocare Health Services Issue Details

Pricing & Lot

Price Band

₹438-460

Face Value

₹2 Per Equity Share

Lot Size

TBA

Managers & Listing

Listing At

BSE, NSE

Lead Managers

ICICI Securities Limited/nAmbit Pvt.Ltd IIFL Capital Services Ltd. Nomura Financial Advisory & Securities (India) Pvt.Ltd.

Registrar

Kfin Technologies Limited

Issue Size

1,89,35,819 shares(aggregating up to ₹871.05 crore)

Nephrocare Health Services IPO Reservation
Nephrocare Health Services IPO offers total 18935819 shares. Out of which 3768224 (19.9%) allocated to QIB, 2827843 (14.93%) allocated to NII,6598301 (34.85%) allocated to RII, 83532 (0.44%) allocated to employees and 5657919 (29.88%) allocated to Anchor investors.
Investor CategoryShares OfferedPercentage
Anchor Investor Shares Offered5657919 (29.88%)29.88%
QIB Shares Offered3768224 (19.9%)19.90%
NII (HNI) Shares Offered2827843 (14.93%)14.93%
bNII > ₹10L1885229 (10%)10.00%
sNII < ₹10L942614 (5%)5.00%
Retail Shares Offered6598301 (34.85%)34.85%
Employee Shares Offered83532 (0.44%)0.44%
Total Shares Offered18935819 (100%)100.00%
GMP & Listing Expectation

GMP (per share)

32.02

Est. Listing Price

492.02

Total Listing Gain (per lot)

0.00

Grey Market Premium (GMP) is an unofficial market indicator. It reflects the premium investors are willing to pay over the issue price before listing. This is not a guaranteed return and can change rapidly.

Valuations
EPS (Pre IPO)₹/-
EPS (Post IPO)₹/-
Price to Book Value7.72
Market Cap4615.34 Cr.
Nephrocare Health Services IPO – FAQs

The Nephrocare Health Services is a 1,89,35,819 shares(aggregating up to ₹871.05 crore) initial public offering. Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide ... You can learn more about what an IPO is in our beginner-friendly guide.

About Nephrocare Health Services

Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023. Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.

Nephrocare Health Services Financials
(₹ in crore)
Company Details

Name

Nephrocare Health Services

Registrar Contact Details

GainIPO data last updated: 01 Jan 2026, 06:33 PM IST

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.